Medicine

Thirty startups have raised CHF 60 million in funding through Tech4Eva, continental Europe’s first program designed specifically for entrepreneurs in the field of femtech, or technology for women’s health. On 7 December, Switzerland’s first femtech conference will mark the end of Tech4Eva’s inaugural year – and kick off the next funding round.

In partnership with Roche, PSI scientists are developing new, potentially more efficient catalysts for manufacturing active substances for drug therapies.

25 November 1996: a world first for PSI’s Center for Proton Therapy in treating a cancer patient using the spot-scanning technique. Meanwhile this technique has become a standard procedure worldwide and since 1996 has been used to treat around 2000 cancer patients at PSI alone – over a third of them children and young people. The fact that the success story started at PSI was more than just a coincidence.

The dire need of dialysis therapies in low- and middle-income countries has prompted the creation of an interdisciplinary and international alliance that brings together experts from key organizations including EPFL.